Monotherapy with P2Y12-inhibitors after dual antiplatelet therapy: Filling gaps in evidence

Whether P2Y12 inhibitor monotherapy (P2Y12-I) is superior to aspirin following DAPT discontinuation post-PCI remains to be established.

Source: International Journal of Cardiology - February 19, 2024 Category: Cardiology Authors: Giuseppe And ò, Luca Lombardo, Giulia Alagna, Antonino Micari, Bruno Francaviglia, Alessia Cascone, Piera Capranzano Source Type: research